Evidence map›Paper›PMID 40531382›Full record

ArticleJournal of fluorescence2025

Red-Light-Driven Photocatalysis with NI-BODIPY-Fullerene Systems for Organic Transformations.

Ezel Öztürk Gündüz, Ümmügülsüm Büyükpolat, Elif Okutan

Abstract read
In one paragraph

Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Iodinated BODIPY-C₆₀ systems bearing bis-phosphonate groups for antimicrobial PDT.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ezel Öztürk GündüzDepartment of Chemistry, Faculty of Science, Gebze Technical University, Gebze, Kocaeli, 41400, Türkiye. ezelozturk@gtu.edu.tr.ORCID http://orcid.org/0000-0002-7770-8811
Ümmügülsüm BüyükpolatDepartment of Chemistry, Faculty of Science, Gebze Technical University, Gebze, Kocaeli, 41400, Türkiye.
Elif OkutanDepartment of Chemistry, Faculty of Science, Gebze Technical University, Gebze, Kocaeli, 41400, Türkiye.ORCID http://orcid.org/0000-0002-6576-4453

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The direct use of low-energy red light for photochemical processes is attractive from a synthetic perspective but challenging to implement in practice. BODIPY-based photosensitizers (PSs) show considerable promise in this area due to their tunable photophysical properties. This study aims to explore the use of mono- and bis-adducts of heavy atom-free NI-BODIPY-fullerene triads, which strongly absorb red light in the 560 to 660 nm range, in red light-irradiated photocatalytic reactions. NI-BODIPY-fullerene photosensitizers possess the ability to generate singlet oxygen (¹O₂), making them effective photosensitizers for the photocatalytic conversion of 1,5-dihydroxynaphtalene (DHN) to juglone and the photooxidation of thioanisole to methyl phenyl sulfoxide. Our photocatalysts are effective, with activities comparable to or even higher than those of readily available commercial systems, achieving 100% conversion of thioanisole to methyl phenyl sulfoxide within 2 h. This study highlights the potential of distyryl-NI-BODIPY-fullerene derivatives as promising photosensitizers/photocatalysts for applications in organic transformations.

Indexed as

BorondipyrrometheneFullereneNapthalimidePhotocatalysisSinglet oxygen

Identifiers

PMID40531382
PMCPMC12718227

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.